Skip to main content

Nasovac-S Influenza Vaccine, Live, Attenuated (Human)

Product overview

Vaccine type
Influenza, seasonal (Trivalent)
Commercial Name
Nasovac-S3 Influenza Vaccine (Human, Live Attenuated )(Liquid)
Manufacturer
Serum Institute of India Pvt. Ltd.
Responsible NRA
Central Drugs Standard Control Organization
Country
India

Prequalification

Prequalification Status
Current
Effective Date

Product description

Pharmaceutical Form
Liquid: ready to use
Presentation
Vial
Number of Doses
1
Route of Administration
Intranasal
Storage Temperature
2-8°C
Vaccine Vial Monitor
Type 2
Secondary Packaging
Carton of 50 vials (active)(50 doses) [Dimensions 18.5x9.5x4.0 cm]
Tertiary Packaging
Box containing 300 vials (300 doses) [Dimensions 31x19x40 cm]
Multidose Vial Policy
Not Applicable.
Vaccine Preservative
none
Cold Chain Volume
14.06 cm3/dose (in secondary packaging)

Attachments

Product Insert - NH